MOH — authorised 25 July 2000
- Status: likely_approved
MOH authorised Abreva on 25 July 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 25 July 2000.
Marketing authorisation holder not available in our data.